Search clinical trials for: apadenoson

Total 7 results

Forest Laboratories

Terminated

A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging

Cardiovascular Disease | Ischemic Heart Disease

United States
Bayer

Completed

Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.

Atrial Fibrillation

Germany
Forest Laboratories

Terminated

A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.

Coronary Artery Disease

United States
Forest Laboratories

Terminated

A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography

Ischemic Heart Disease | Heart Disease

United States
Bayer

Withdrawn

Capadenoson in Angina Pectoris

Chronic Stable Angina

Italy, Hungary, Poland, Slovakia, Israel, Czech Republic
Forest Laboratories
PPD

Terminated

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI (ASPECT2)

Coronary Artery Disease

United States, Argentina, Belgium, Brazil, Netherlands
Forest Laboratories
PPD

Terminated

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI (ASPECT)

Coronary Artery Disease

United States, Brazil

3

Subscribe